Moderate long term
Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics
Home / Health News / 2007 / November 2007 / November 23, 2007
Moderate, long-term pain medication use does not impair driving abilities

Health News

Structure of key breast cancer target enzyme unraveled
A researcher at Hauptman-Woodward Medical Research Institute has moved a step closer to a cure, and possibly the prevention, of the most common type of breast cancer. ANI

Smoking claimed 673,000 Chinese lives in 2005
A multinational research team, led by scientists at Tulane University School of Public Health and Tropical Medicine, has lent more force to the suggestion that smoking is a significant risk factor for mortality and disease. ANI

Genetic mutations can predict childhood leukaemia relapse
A collaborative study by American researchers has revealed that changes in a gene called IKAROS can help predict a high likelihood of relapse in children with acute lymphoblastic leukaemia (ALL). ANI

Moderate, long-term pain medication use does not impair driving abilities

A new study has revealed that moderate, long-term pain medication use does not impair a persons ability to drive safely.

Washington, Nov 23 : A new study has revealed that moderate, long-term pain medication use does not impair a person's ability to drive safely.

The study, conducted by Dr. Asokumar Buvanendran, associate professor, Department of Anesthesiology at Rush University Medical Center, Chicago, was presented at the American Society of Anesthesiologists meeting in San Francisco on October 13.

Opioid pain relievers, such as morphine and other narcotics, carry warning labels insisting patients not to drive or operate heavy machinery during use. In addition, drivers under the influence of pain medication are typically subjected to the same laws and penalties as drivers under the influence of alcohol.

And yet, in a recent, preliminary study Buvanendran found no difference in the "driving skills and reaction times" of patients taking morphine compared to non-medicated drivers.

For the study, Buvanendran compared two groups of patients: 51 patients chronically receiving oral morphine and 49 patients (the control group) receiving no pain medication.

Each study participant drove for approximately 12 minutes in a driving simulator that measured deviation from the center of the road, weaving, the number of accidents, and reaction time to surprise events.

It was found that the amount of weaving was 3.83 feet for both sets of drivers, and the opioid group had 5.33 collisions compared to the non-opioid group with 5.04 (no statistical difference). Reaction time also was similar for both groups: 0.69 seconds for the controlled group and 0.67 for the opioid group.

Buvanendran said the findings suggested that patients who need, long-term pain medicine actually may 'become tolerant' to the medication side effects that potentially impair function.

He said that in the future, these patients might be able to live "like normal functioning people, without the stigma and limitations now associated with long-term pain medication use."

Fewer restrictions also will allow patients to travel more easily and access treatments, ultimately improving their quality of life.

This research model will be used in future studies to assess the effects of other types of anesthetics and pain medication.

ANI

January 8, 2009

January 7, 2009

January 6, 2009

January 5, 2009

January 4, 2009

January 3, 2009